These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15952908)

  • 21. [Cocaine and crack addiction: a growing public health problem].
    Haas C; Karila L; Lowenstein W
    Bull Acad Natl Med; 2009 Apr; 193(4):947-62; discussion 962-3. PubMed ID: 20120283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus.
    Bastien N; Trudel M; Simard C
    Virology; 1997 Jul; 234(1):118-22. PubMed ID: 9234952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic unilateral stimulation of the nucleus accumbens at high or low frequencies attenuates relapse to cocaine seeking in an animal model.
    Hamilton J; Lee J; Canales JJ
    Brain Stimul; 2015; 8(1):57-63. PubMed ID: 25457212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cocaine catalytic antibodies: the primary importance of linker effects.
    Matsushita M; Hoffman TZ; Ashley JA; Zhou B; Wirsching P; Janda KD
    Bioorg Med Chem Lett; 2001 Jan; 11(2):87-90. PubMed ID: 11206477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a therapeutic vaccine for the treatment of cocaine addiction.
    Fox BS
    Drug Alcohol Depend; 1997 Dec; 48(3):153-8. PubMed ID: 9449013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A human recombinant monoclonal antibody to cocaine: Preparation, characterization and behavioral studies.
    Eubanks LM; Ellis BA; Cai X; Schlosburg JE; Janda KD
    Bioorg Med Chem Lett; 2014 Oct; 24(19):4664-4666. PubMed ID: 25205191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cocaine vaccine dAd5GNE protects against moderate daily and high-dose "binge" cocaine use.
    Havlicek DF; Rosenberg JB; De BP; Hicks MJ; Sondhi D; Kaminsky SM; Crystal RG
    PLoS One; 2020; 15(11):e0239780. PubMed ID: 33253224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuse.
    Brimijoin S; Shen X; Orson F; Kosten T
    Expert Rev Vaccines; 2013 Mar; 12(3):323-32. PubMed ID: 23496671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of a repeated dose of a recombinant humanized anti-cocaine monoclonal antibody on cocaine self-administration in rats.
    Wetzel HN; Tsibulsky VL; Norman AB
    Drug Alcohol Depend; 2016 Nov; 168():287-292. PubMed ID: 27736682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The concept of pharmacologic cocaine interception as a treatment for drug abuse.
    Gao Y; Orson FM; Kinsey B; Kosten T; Brimijoin S
    Chem Biol Interact; 2010 Sep; 187(1-3):421-4. PubMed ID: 20219449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunocontraception: Filamentous Bacteriophage as a Platform for Vaccine Development.
    Samoylova TI; Braden TD; Spencer JA; Bartol FF
    Curr Med Chem; 2017 Nov; 24(35):3907-3920. PubMed ID: 28901276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-cocaine vaccines: antibody protection against relapse.
    Kantak KM
    Expert Opin Pharmacother; 2003 Feb; 4(2):213-8. PubMed ID: 12562311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gq-DREADD Selectively Initiates Glial Glutamate Release and Inhibits Cue-induced Cocaine Seeking.
    Scofield MD; Boger HA; Smith RJ; Li H; Haydon PG; Kalivas PW
    Biol Psychiatry; 2015 Oct; 78(7):441-51. PubMed ID: 25861696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization for prevention and treatment of cocaine abuse: legal and ethical implications.
    Cohen PJ
    Drug Alcohol Depend; 1997 Dec; 48(3):167-74. PubMed ID: 9449015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A shot against cocaine addiction.
    Lab Anim (NY); 2001 Apr; 30(4):12-3. PubMed ID: 11385738
    [No Abstract]   [Full Text] [Related]  

  • 36. Antigen-specific therapy of EAE via intranasal delivery of filamentous phage displaying a myelin immunodominant epitope.
    Rakover IS; Zabavnik N; Kopel R; Paz-Rozner M; Solomon B
    J Neuroimmunol; 2010 Aug; 225(1-2):68-76. PubMed ID: 20546938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accelerating cocaine metabolism as an approach to the treatment of cocaine abuse and toxicity.
    Schindler CW; Goldberg SR
    Future Med Chem; 2012 Feb; 4(2):163-75. PubMed ID: 22300096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the feasibility of an anti-idiotypic cocaine vaccine: analysis of the specificity of anticocaine antibodies (Ab1) capable of inducing Ab2beta anti-idiotypic antibodies.
    Schabacker DS; Kirschbaum KS; Segre M
    Immunology; 2000 May; 100(1):48-56. PubMed ID: 10809958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dacryocystitis secondary to intranasal cocaine abuse: a case report and literature review.
    Allard FD; Yee EU; Freitag SK
    Orbit; 2013 Dec; 32(6):405-8. PubMed ID: 23909455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxytocin Reduces Cocaine Cued Fos Activation in a Regionally Specific Manner.
    Leong KC; Freeman LR; Berini CR; Ghee SM; See RE; Reichel CM
    Int J Neuropsychopharmacol; 2017 Oct; 20(10):844-854. PubMed ID: 28977525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.